Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 7 Ovarian Neoplasms 6 Pancreatic Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Urogenital Neoplasms 3 Stomach Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Gastrointestinal Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Rectal Neoplasms 2 Multiple Myeloma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Myelodysplastic Syndromes 1

Interventions

Cyclophosphamide 26 fludarabine 18 Dexamethasone 17 pembrolizumab 12 Rituximab 11 Etoposide 10 venetoclax 9 pomalidomide 9 Gemcitabine 9 fludarabine phosphate 7 daratumumab 7 Lenalidomide 7 Bortezomib 7 carfilzomib 6 obinutuzumab 5 glofitamab 5 Vincristine 5 Temozolomide 5 Prednisone 5 Nivolumab 5 Immunotherapy, Adoptive 5 Cisplatin 5 Calcium Dobesilate 5 selinexor 4 cemiplimab 4 Doxorubicin 4 Cytarabine 4 Carboplatin 4 zanubrutinib 3 ruxolitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × aldesleukin × 90 days × Clear all

NCT04347616 2026-03-16

NK4AML

Radboud University Medical Center

Phase 1/2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡